NOT-CA-20-084: Notice of Changes to the Dates in the Final Receipt, Review, Council, and Award Cycle and to the Expiration Date of PAR-19-101, "Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)"

Notice of Changes to the Dates in the Final Receipt, Review, Council, and Award Cycle and to the Expiration Date of PAR-19-101, "Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)"

Notice Number:

NOT-CA-20-084

Key Dates

Release Date:

July 7, 2020

Related Announcements

PAR-19-101 - Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to revise the final "Key Date" for PAR-19-101,“Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional).”

In Part 1 of PAR-19-101, under Key Dates, the final “Application Due Date” now has a revised due date of September 30, 2020; "Scientific Merit Review" now has a revised date of January/February 2021; "Advisory Council Review" now has a revised date of May 2021; and "Earliest Start Date" has a revised date of July 2021.

I. Part 1 Key Dates in PAR-19-101
Currently Reads:

Application Due Date(s)

January 30, 2019; July 30, 2019; January 30, 2020; July 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review
April/May 2019; October/November 2019; April/May 2020; October/November 2020

Advisory Council Review
August 2019; January 2020; August 2020; January 2021

Earliest Start Date
September 2019; February 2020; September 2020; February 2021

Expiration Date
July 31, 2020

II. Part 1 Key Dates in PAR-19-101

Modified (by this Notice) to Read (in italics):

Application Due Date(s)
January 30, 2019; July 30, 2019; January 30, 2020; September 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review
April/May 2019; October/November 2019; April/May 2020; January/February 2021

Advisory Council Review
August 2019; January 2020; August 2020; May 2021

Earliest Start Date
September 2019; February 2020; September 2020; July 2021

Expiration Date
October 1, 2020

III. Part 1 Key Dates in PAR-19-101 Remaining Unmodified:

Letter of Intent Due Date(s)
30 days prior to the Application Due Date

All other aspects of PAR-19-101 remain unchanged.

Inquiries

Please direct all inquiries to:

Nastaran Zahir, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6333
Email: [email protected]